Smaller biotechs Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
16:01
Jan 08
Jan 08
Biotech M&A green light accelerates.
Large pharma including Lilly and AbbVie are set to pick off smaller biotechs, and consolidation should pick up in 2026 as FTC deregulation, lower rates, greater drug-pricing visibility, and 2028-29 patent cliffs create a green light for M&A; small companies near approval without sales forces are targets.
HIGH
About Smaller biotechs Investor Commentary
Across the available history and selected sources, Buzzberg tracks Smaller biotechs across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Michael Yee.